Anti-HMGB1 Neutralizing Antibody Ameliorates Neutrophilic Airway Inflammation by Suppressing Dendritic Cell-mediated Th17 Polarization

Overview

Journal Mediators Inflamm

Publisher Wiley

Specialties Biochemistry
Pathology

Date 2014 Jun 25

PMID 24959003

Citations 25

Authors

Fang Zhang

Gang Huang

Bo Hu

Li-Ping Fang

E-Hong Cao

Xiao-Feng Xin

Yong Song

Yi Shi

Affiliations

Soon will be listed here.

Abstract

We demonstrate that high mobility group box 1 protein (HMGB1) directs Th17 skewing by regulating dendritic cell (DC) function. First, our in vitro studies reveal that recombinant HMGB1 (rHMGB1) activates myeloid DCs to produce IL-23 in vitro, and rHMGB1-activated DCs prime naïve lymphocytes to produce the Th17 cytokine IL-17A. Second, we demonstrate that anti-HMGB1 neutralizing antibody attenuates HMGB1 expression, neutrophilic inflammation, airway hyperresponsiveness, and Th17-related cytokine secretion in vivo by using a murine model of neutrophilic asthma induced by ovalbumin (OVA) plus lipopolysaccharide (LPS). Furthermore, anti-HMGB1 neutralizing antibody decreases the number of Th17 cells in lung cells and suppresses the production of IL-23 by lung CD11C(+) APCs. Finally, we show that intranasal adoptive transfer of rHMGB1-activated DCs was sufficient to restore lung neutrophilic inflammation and the Th17 response in a DC-driven model of asthma, whereas the transfer of rHMGB1 plus anti-HMGB1-treated mDCs significantly reduced these inflammation phenotypes. These data suggest, for the first time, that HMGB1 drives the DC-polarized Th17-type response in allergic lung inflammation and that blocking HMGB1 may benefit the attenuation of neutrophilic airway inflammation in asthma.

Citing Articles

HMGB1/RAGE Signaling Regulates Th17/IL-17 and Its Role in Bronchial Epithelial-Mesenchymal Transformation.

Sun J, Jiang Y, Li L, Li R, Ling F, Du X Curr Mol Med. 2023; 24(11):1401-1412.

PMID: 37921188 DOI: 10.2174/0115665240249953231024060610.

Asthma-associated bacterial infections: Are they protective or deleterious?.

de Campos Fraga-Silva T, Boko M, Martins N, Cetlin A, Russo M, Vianna E J Allergy Clin Immunol Glob. 2023; 2(1):14-22.

PMID: 37780109 PMC: 10510013. DOI: 10.1016/j.jacig.2022.08.003.

CXCL12/CXCR4 Axis is Involved in the Recruitment of NK Cells by HMGB1 Contributing to Persistent Airway Inflammation and AHR During the Late Stage of RSV Infection.

Chen S, Tang W, Yu G, Tang Z, Liu E J Microbiol. 2023; 61(4):461-469.

PMID: 36781697 DOI: 10.1007/s12275-023-00018-8.

Targeting Inflammation Driven by HMGB1 in Bacterial Keratitis-A Review.

Hazlett L, McClellan S, Somayajulu M, Bessert D Pathogens. 2021; 10(10).

PMID: 34684184 PMC: 8538492. DOI: 10.3390/pathogens10101235.

IFP35 family proteins promote neuroinflammation and multiple sclerosis.

Jing X, Yao Y, Wu D, Hong H, Feng X, Xu N Proc Natl Acad Sci U S A. 2021; 118(32).

PMID: 34362845 PMC: 8364186. DOI: 10.1073/pnas.2102642118.

References

Deckers J, Madeira F, Hammad H . Innate immune cells in asthma. Trends Immunol. 2013; 34(11):540-7. DOI: 10.1016/j.it.2013.08.004. View

Ebina M, Taniguchi H, Miyasho T, Yamada S, Shibata N, Ohta H . Gradual increase of high mobility group protein b1 in the lungs after the onset of acute exacerbation of idiopathic pulmonary fibrosis. Pulm Med. 2011; 2011:916486. PMC: 3100576. DOI: 10.1155/2011/916486. View

Kim Y, Hong S, Choi J, Shin T, Moon H, Choi E . Vascular endothelial growth factor is a key mediator in the development of T cell priming and its polarization to type 1 and type 17 T helper cells in the airways. J Immunol. 2009; 183(8):5113-20. PMC: 3385973. DOI: 10.4049/jimmunol.0901566. View

Wakashin H, Hirose K, Iwamoto I, Nakajima H . Role of IL-23-Th17 cell axis in allergic airway inflammation. Int Arch Allergy Immunol. 2009; 149 Suppl 1:108-12. DOI: 10.1159/000211382. View

Zhang F, Huang G, Hu B, Song Y, Shi Y . A soluble thymic stromal lymphopoietin (TSLP) antagonist, TSLPR-immunoglobulin, reduces the severity of allergic disease by regulating pulmonary dendritic cells. Clin Exp Immunol. 2011; 164(2):256-64. PMC: 3087918. DOI: 10.1111/j.1365-2249.2011.04328.x. View

He Z, Shotorbani S, Jiao Z, Su Z, Tong J, Liu Y . HMGB1 promotes the differentiation of Th17 via up-regulating TLR2 and IL-23 of CD14+ monocytes from patients with rheumatoid arthritis. Scand J Immunol. 2012; 76(5):483-90. DOI: 10.1111/j.1365-3083.2012.02759.x. View

Marland G, Bakker A, Adema G, Figdor C . Dendritic cells in immune response induction. Stem Cells. 1996; 14(5):501-7. DOI: 10.1002/stem.140501. View

Jaffar Z, Ferrini M, Girtsman T, Roberts K . Antigen-specific Treg regulate Th17-mediated lung neutrophilic inflammation, B-cell recruitment and polymeric IgA and IgM levels in the airways. Eur J Immunol. 2009; 39(12):3307-14. PMC: 2849980. DOI: 10.1002/eji.200939498. View

Pearce E, Kane C, Sun J . Regulation of dendritic cell function by pathogen-derived molecules plays a key role in dictating the outcome of the adaptive immune response. Chem Immunol Allergy. 2005; 90:82-90. DOI: 10.1159/000088882. View

10.

Traves S, Donnelly L . Th17 cells in airway diseases. Curr Mol Med. 2008; 8(5):416-26. DOI: 10.2174/156652408785160998. View

11.

Klune J, Dhupar R, Cardinal J, Billiar T, Tsung A . HMGB1: endogenous danger signaling. Mol Med. 2008; 14(7-8):476-84. PMC: 2323334. DOI: 10.2119/2008-00034.Klune. View

12.

Allam J, Duan Y, Heinemann F, Winter J, Gotz W, Deschner J . IL-23-producing CD68(+) macrophage-like cells predominate within an IL-17-polarized infiltrate in chronic periodontitis lesions. J Clin Periodontol. 2011; 38(10):879-86. DOI: 10.1111/j.1600-051X.2011.01752.x. View

13.

Musumeci D, Roviello G, Montesarchio D . An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacol Ther. 2013; 141(3):347-57. DOI: 10.1016/j.pharmthera.2013.11.001. View

14.

Dumitriu I, Baruah P, Valentinis B, Voll R, Herrmann M, Nawroth P . Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol. 2005; 174(12):7506-15. DOI: 10.4049/jimmunol.174.12.7506. View

15.

Kim Y, Oh S, Jeon S, Park H, Lee S, Chun E . Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthma. J Immunol. 2007; 178(8):5375-82. DOI: 10.4049/jimmunol.178.8.5375. View

16.

Zhang F, Huang G, Hu B, Song Y, Shi Y . Induction of immune tolerance in asthmatic mice by vaccination with DNA encoding an allergen-cytotoxic T lymphocyte-associated antigen 4 combination. Clin Vaccine Immunol. 2011; 18(5):807-14. PMC: 3122522. DOI: 10.1128/CVI.00434-10. View

17.

Bai H, Cheng J, Gao X, Joyee A, Fan Y, Wang S . IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. J Immunol. 2009; 183(9):5886-95. DOI: 10.4049/jimmunol.0901584. View

18.

Lin X, Yang H, Sakuragi T, Hu M, Mantell L, Hayashi S . Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis. Am J Physiol Lung Cell Mol Physiol. 2005; 289(4):L583-90. DOI: 10.1152/ajplung.00091.2005. View

19.

Manfredi A, Capobianco A, Esposito A, De Cobelli F, Canu T, Monno A . Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes. J Immunol. 2008; 180(4):2270-5. DOI: 10.4049/jimmunol.180.4.2270. View

20.

Mishra A, Yao X, Levine S . From bedside to bench to clinic trials: identifying new treatments for severe asthma. Dis Model Mech. 2013; 6(4):877-88. PMC: 3701207. DOI: 10.1242/dmm.012070. View